CR overview
| CR: | SETD2 | |
| Accession: | Q9BYW2 | |
| Protein names: | Histone-lysine N-methyltransferase SETD2 | |
| Function type: | Histone Modifier | |
| Histone type: | Writer | |
| Methytor type: | Unkown | |
| Aliases: | SET domain containing;Histone methyltransferases;SET-HMT | |
| PMID: | 32619406 31300513 28753426 | |
| Disease: | 33 | |
| Go term: | 38 | |
| Pathway: | 3 | |
| Hallmark: | 2 | |
| Super Enhancer: | chr3:47114667-47217916 |
|
| Enhancer: |
chr3:47040060-47040200 chr3:47023260-47023420 chr3:47028500-47030150 chr3:47619420-47620080 chr3:47282510-47284460 chr3:46939960-46940150 chr3:46965160-46966940 chr3:47031080-47032700 chr3:47281680-47282290 chr3:47307370-47308460 chr3:47038080-47038240 chr3:47037540-47037760 chr3:47038320-47038440 chr3:47038540-47038740 chr3:47056730-47057890 chr3:47058740-47059120 chr3:47362120-47363460 chr3:47403670-47404950 chr3:47474190-47476490 chr3:47522450-47524390 chr3:47552720-47555030 chr3:47037120-47037200 chr3:47464030-47465420 chr3:47039720-47039950 chr3:47130500-47132250 chr3:47141820-47142940 chr3:47465540-47466970 chr3:46923760-46925000 chr3:47675330-47676670 chr3:47059230-47061240 chr3:46935500-46937220 chr3:47040370-47040440 chr3:46964000-46964810 chr3:46964850-46965090 chr3:46970720-46971160 chr3:46987050-46988510 chr3:46993370-46994240 chr3:46996320-46998250 chr3:46998280-46999090 chr3:47002770-47003390 chr3:47216270-47218600 chr3:47332400-47332880 chr3:46870380-46871890 chr3:46991440-46993090 chr3:46994340-46996160 chr3:47011410-47013810 chr3:47015290-47016170 chr3:47154240-47155360 chr3:47337480-47337750 chr3:47338520-47339020 chr3:47388310-47390680 chr3:47479220-47479640 chr3:47594620-47595400 chr3:47301800-47302720 chr3:47455880-47456060 chr3:46973920-46974730 chr3:46974740-46975130 chr3:47063340-47065110 chr3:47137220-47139440 chr3:47155500-47157020 chr3:46971750-46973770 chr3:47308560-47308660 chr3:46898580-46899350 chr3:46956660-46957670 chr3:47514800-47517280 chr3:47393410-47395750 chr3:47446570-47447230 chr3:47447280-47447400 chr3:47462520-47463930 chr3:47583750-47585010 chr3:46953850-46955950 chr3:47041900-47042490 chr3:47081980-47083140 chr3:47096360-47097640 chr3:47113080-47115380 chr3:47083390-47084050 chr3:47158240-47160240 chr3:47256680-47257260 chr3:47286420-47286910 chr3:47287000-47287680 chr3:47448100-47448190 chr3:47448240-47448610 chr3:47449980-47450260 chr3:47456670-47458170 chr3:47535130-47537120 chr3:47543340-47545140 chr3:47609830-47610560 chr3:47610720-47610970 chr3:47764250-47764820 chr3:47844700-47846810 chr3:47004020-47005450 chr3:47575070-47576460 chr3:47455590-47455660 chr3:47456140-47456310 chr3:47461200-47462040 chr3:47462260-47462420 chr3:46945300-46946110 chr3:47636190-47636840 chr3:47497110-47497880 chr3:46801080-46802120 chr3:46852820-46855090 chr3:47150110-47151210 chr3:47194150-47194640 chr3:47435200-47437460 chr3:47382170-47384200 chr3:46902620-46904230 chr3:46940350-46940790 chr3:47079270-47080750 chr3:47095760-47096280 chr3:47197810-47198140 chr3:47453690-47453770 chr3:47453910-47454000 chr3:47454120-47454190 chr3:47454930-47455180 chr3:47456480-47456580 chr3:47458200-47458610 chr3:47458700-47458790 chr3:47459320-47459620 chr3:47459740-47459810 chr3:47460010-47460140 chr3:47460330-47460810 |
|
| Promoter: |
chr3:47162113-47166113 |
ChIP-seq based regulatory details of SETD2
| Sample ID | CR | Biosample type | Biosample term name | File accession | Experiment accession | Source |
|---|
Downstream target genes of SETD2
Upstream regulatory details of SETD2
Protein-protein interaction of SETD2
Annotation of SETD2
TCGA cancer survival map of SETD2
Other information of SETD2